Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
February 12, 2008
Assessment of external beam radiation technology for dose escalation and normal tissue protection in the treatment of prostate cancer
David J D'Ambrosio, Alan Pollack, Eleanor E R Harris, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 12, 2012
Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer
Andre Konski, Tianyu Li, Michael Christensen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 3, 2014
Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer
Andre Konski, Joshua E Meyer, Michael Joiner, et al.
Practical Radiation Oncology
|
November 1, 2013
Continuous localization technologies for radiotherapy delivery: Report of the American Society for Radiation Oncology Emerging Technology Committee
David J D'Ambrosio, John Bayouth, Indrin J Chetty, et al.
American Journal of Clinical Oncology
|
October 7, 2006
Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer
Benjamin Movsas, Hasmik Diratzouian, Alexandra Hanlon, et al.
The Journal of Urology
|
September 18, 2007
Prostate cancer risk assessment program: a 10-year update of cancer detection
Veda N Giri, Jennifer Beebe-Dimmer, Mark Buyyounouski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 2011
Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline
Stephen Lutz, Lawrence Berk, Eric Chang, et al.
JAMA
|
March 6, 2008
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial
William F Regine, Kathryn A Winter, Ross A Abrams, et al.
Cancer
|
June 14, 2025
A phase 1 dual-dose escalation study of radiation and nab-paclitaxel in patients with unresectable and borderline resectable pancreatic cancer
Uri Amit, James M Metz, John P Plastaras, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 25, 2019
Executive Summary of the American Radium Society Appropriate Use Criteria for Local Excision in Rectal Cancer
Suzanne Russo, Christopher J Anker, May Abdel-Wahab, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
International Journal of Radiation Oncology, Biology, Physics
|
February 12, 2008
Assessment of external beam radiation technology for dose escalation and normal tissue protection in the treatment of prostate cancer
David J D'Ambrosio, Alan Pollack, Eleanor E R Harris, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 12, 2012
Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer
Andre Konski, Tianyu Li, Michael Christensen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 3, 2014
Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer
Andre Konski, Joshua E Meyer, Michael Joiner, et al.
Practical Radiation Oncology
|
November 1, 2013
Continuous localization technologies for radiotherapy delivery: Report of the American Society for Radiation Oncology Emerging Technology Committee
David J D'Ambrosio, John Bayouth, Indrin J Chetty, et al.
American Journal of Clinical Oncology
|
October 7, 2006
Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer
Benjamin Movsas, Hasmik Diratzouian, Alexandra Hanlon, et al.
The Journal of Urology
|
September 18, 2007
Prostate cancer risk assessment program: a 10-year update of cancer detection
Veda N Giri, Jennifer Beebe-Dimmer, Mark Buyyounouski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 2011
Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline
Stephen Lutz, Lawrence Berk, Eric Chang, et al.
JAMA
|
March 6, 2008
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial
William F Regine, Kathryn A Winter, Ross A Abrams, et al.
Cancer
|
June 14, 2025
A phase 1 dual-dose escalation study of radiation and nab-paclitaxel in patients with unresectable and borderline resectable pancreatic cancer
Uri Amit, James M Metz, John P Plastaras, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 25, 2019
Executive Summary of the American Radium Society Appropriate Use Criteria for Local Excision in Rectal Cancer
Suzanne Russo, Christopher J Anker, May Abdel-Wahab, et al.
Page
of 9